Pre-market Movers: RETA, ONCS, LION, NVAX, SRPT…

By RTTNews Staff Writer   ✉   | Published:

The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 06.45 A.M. ET).

In the Green

Reata Pharmaceuticals, Inc. (RETA) is up over 160% at $81.16.
OncoSec Medical Incorporated (ONCS) is up over 94% at $2.10.
Lionheart III Corp (LION) is up over 48% at $21.67.
Sarepta Therapeutics, Inc. (SRPT) is up over 20% at $146.55.
B&G Foods, Inc. (BGS) is up over 16% at $14.70.
Focus Universal Inc. (FCUV) Nis up over 16% at $5.88.
Duolingo, Inc. (DUOL) is up over 10% at $100.00.
Tuya Inc. (TUYA) is up over 8% at $2.24.
JinkoSolar Holding Co., Ltd. (JKS) is up over 7% at $56.79.
Baidu, Inc. (BIDU) is up over 6% at $146.91.
RLX Technology Inc. (RLX) is up over 6% at $2.07.
Alibaba Group Holding Limited (BABA) is up over 5% at $92.96.

In the Red

Novavax, Inc. (NVAX) is down over 24% at $7.00.
Marqeta, Inc. (MQ) is down over 20% at $4.60.
Beamr Imaging Ltd. Ordinary Share (BMR) is down over 16% at $3.06.
BrightSpire Capital, Inc. (BRSP) is down over 15% at $6.23.
Verde Clean Fuels, Inc. (VGAS) is down over 14% at $10.01.
iHeartMedia, Inc. (IHRT) is down over 13% at $6.29.
2seventy bio, Inc. (TSVT) is down over 12% at $11.79.
FIGS, Inc. (FIGS) is down over 10% at $8.20.
Rivian Automotive, Inc. (RIVN) is down over 8% at $17.60.
AMC Entertainment Holdings, Inc. (AMC) is down over 8% at $6.56.
iQIYI, Inc. (IQ) is down over 7% at $7.13.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
U.S. retailers Abercrombie & Fitch Co. (ANF), Dollar Tree Inc. (DLTR) and Kohl's Corp. (KSS) on Wednesday reported results for the fourth quarter, with profit at Abercrombie & Fitch declining, and profit at Dollar Tree edging down from last year, while Kohl's slipped to a loss. While reporting financial results for the fourth quarter on Wednesday, Dollar Tree, Inc. (DLTR) initiated earnings, sales and same-store sales guidance for the first quarter and for the full-year 2023. For the first quarter, the company estimates earnings in a range of $1.46 to $1.56 per share on... The U.S. Food and Drug Administration said it has taken steps to restrict unlawful imports of xylazine, an animal tranquilizer that has increasingly been found in illicit drugs, into the United States. With this, the Federal regulator aims to prevent the drug from entering the U.S. market for illicit purposes, while maintaining availability for legitimate use in animals.